Effect of Mutations in T2DM Susceptibility Genes on the Expression of Susceptibility Genes in Patients With T2DM and Controls

NARecruitingINTERVENTIONAL
Enrollment

300

Participants

Timeline

Start Date

January 1, 2024

Primary Completion Date

January 31, 2028

Study Completion Date

January 31, 2028

Conditions
Type 2 Diabetes MellitusGene PolymorphismsGenetic MutationsSusceptibility, Genetic
Interventions
DRUG

Fresh normal pancreatic tissues or adjacent tissues of pancreatic cancer were collected from controls and T2DM patients without hypoglycemic drugs

Compared with newly diagnosed T2DM patients, healthy subjects in the control group had normal levels of blood glucose, lipids, glycated hemoglobin levels, etc. Fresh normal pancreatic tissues or adjacent tissues of pancreatic cancer were collected before taking antidiabetic drugs in both groups.

DRUG

Fresh blood samples were collected from healthy subjects and T2DM patients without hypoglycemic drugs

"The newly diagnosed T2DM group should not have taken antidiabetic drugs and meet the diagnosis of T2DM. Fresh blood samples were collected before medication for detection.~In the control group (healthy subjects), the indicators of physical examination were within the normal range and no hypoglycemic drugs were taken. Similarly, fresh blood samples should be taken for testing."

Trial Locations (1)

221006

RECRUITING

China, Jiangsu, Department of Endocrinology, Xuzhou

All Listed Sponsors
lead

The Affiliated Hospital of Xuzhou Medical University

OTHER